Trump Signs Order to Split MMR Vaccine, CMS Ends Medicaid Funding for Youth Gender Transitions

Two health policy moves landed back to back this week. On Monday, August 10, President Trump signed an executive order calling for the measles, mumps and rubella vaccine to be split into three separate shots. On Tuesday, the Centers for Medicare & Medicaid Services finalized a rule ending Medicaid and CHIP funding for gender-affirming surgeries and hormone treatments for minors.

The MMR order

Trump said the combined MMR shot could be "quite lethal," according to CNBC. He offered no evidence for that claim. The vaccine has been studied in large-scale trials for decades and is considered safe and effective by the medical establishment.

The White House framed the order differently. A White House fact sheet dated August 10 said the executive order delivers "Gold Standard Childhood Vaccine Recommendations" based on an HHS scientific assessment from January 2026 that compared U.S. vaccine schedules to those of "peer, developed countries" and evaluated uptake, trust, and evidence gaps. The stated goal, per the White House, is maximizing parental choice.

Doctors reject the safety claim outright. Neil Maniar, a public health professor at Northeastern University, told CNBC that splitting the vaccine "creates a new problem" rather than solving one, calling the rationale "based on false scientific rationale and political ideology." He warned that three separate shots would mean three separate doctor's visits, raising the odds that kids miss doses altogether.

There's a legitimate logistical question buried under the politics here. Parents juggling work schedules and pediatrician availability already struggle to keep kids on track for combination shots. Multiplying the number of required visits is a real access problem, not just a talking point, and it's one the order doesn't appear to address.

CNBC traced the origin of the split-shot idea to Andrew Wakefield, the British gastroenterologist whose 1998 paper linking the MMR vaccine to autism was retracted after his research was discredited and his medical license revoked. That history matters. Whatever the White House's stated rationale, the underlying premise that separating the shots reduces risk has no support in the peer-reviewed record.

Manufacturers Merck and GSK have little financial reason to build standalone shots, according to CNBC's reporting, since the regulatory and trial process would take years and any product would likely reach market well after Trump leaves office. Dr. Andrew Racine, president of the American Academy of Pediatrics, told reporters that declining MMR uptake has already contributed to the largest U.S. measles case count in decades. A 2025 KFF/Washington Post survey found roughly 9% of parents report skipping or delaying the MMR shot for their kids.

CMS cuts funding for youth gender treatments

A day later, CMS announced its final rule ending federal Medicaid and CHIP funding for gender-affirming surgeries and hormone therapy for minors, set to take effect October 13, according to Fierce Healthcare and the Associated Press as carried by News4Jax and Newsday.

HHS Secretary Robert F. Kennedy Jr. said the procedures "fail to meet the evidentiary standard our children deserve." CMS Administrator Dr. Mehmet Oz said the move follows "the science" and protects children "from potentially irreversible harm." Trump posted that the government won't pay for children to undergo "barbaric surgeries and practices."

CMS said its conclusion rests on an HHS review that found "significant evidence gaps" and "documented serious safety concerns," and noted the American Society of Plastic Surgeons has updated its position, stating earlier this year it found "insufficient evidence" that the benefits of surgical interventions on minors with gender dysphoria outweigh the risks.

The position splits organized medicine. The American Academy of Pediatrics, the American Medical Association and the American Psychological Association all disagree with CMS's conclusion and continue to support access to gender-affirming care for minors, according to Fierce Healthcare.

The rule carves out mental health coverage, which remains funded. Kids already on hormone therapy get a tapering window, with coverage phasing out for those receiving treatment as of April 2027. Surgical procedures for minors are rare to begin with; puberty blockers and hormone treatments are far more common, according to the Associated Press.

At least 27 states already ban gender-affirming care for minors, and many hospitals in states without bans have stopped offering some treatments regardless, per AP reporting. CMS did not respond to questions Tuesday about how much taxpayer money the change actually affects.

Opposition is immediate and organized. GLBTQ Legal Advocates and Defenders legal director Josh Rovenger called the rule a barrier between parents and medical decision-making and said it will be challenged in court. Human Rights Campaign President Kelley Robinson called the policy an act of "terrorizing trans youth and their families." HRC is already suing the administration over a related effort to bar this coverage under federal employee benefit plans.

Both policies will likely face courtroom challenges and determine how doctors, hospitals and insurers implement rules that most professional associations say aren't supported by the evidence CMS cited.